Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease

NCT00224263 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
360
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Xuanwu Hospital, Beijing